Management of a patient with borderline resectable pancreatic cancer. Case report and review

Anand P Shah; Jonathan B Strauss; William T Leslie; Amar Shah; Brett Mahon; Ross A Abrams

Management of a patient with borderline resectable pancreatic cancer. Case report and review

Oncology (Williston Park). 2008 Nov 30;22(13):1524-9.

Authors

Anand P Shah¹, Jonathan B Strauss, William T Leslie, Amar Shah, Brett Mahon, Ross A Abrams

Affiliation

¹ Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612, USA.

PMID: 19133606

Abstract

The definition and management of borderline resectability for periampullary pancreatic adenocarcinoma are evolving. In this case report, we discuss the presentation, workup, and therapeutic management of a 40-year-old man who presented with borderline resectable, periampullary pancreatic cancer and underwent a margin-negative resection following neoadjuvant chemoradiotherapy.

Publication types

Case Reports
Comment
Review

MeSH terms

Adenocarcinoma / drug therapy
Adenocarcinoma / pathology
Adenocarcinoma / radiotherapy
Adenocarcinoma / surgery
Adenocarcinoma / therapy*
Adult
Ampulla of Vater
Antimetabolites, Antineoplastic / therapeutic use
Chemotherapy, Adjuvant
Deoxycytidine / analogs & derivatives
Deoxycytidine / therapeutic use
Gemcitabine
Humans
Male
Neoadjuvant Therapy / methods*
Pancreatic Neoplasms / drug therapy
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / radiotherapy
Pancreatic Neoplasms / surgery
Pancreatic Neoplasms / therapy*
Pancreaticoduodenectomy*
Postoperative Care
Preoperative Care
Radiotherapy, Adjuvant
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Gemcitabine